ATLANTA--(BUSINESS WIRE)--The Ovarian Cancer Institute, an organization dedicated to ovarian cancer awareness, prevention and research, in collaboration with the Georgia Institute of Technology, today announced it has developed a method to detect ovarian cancer that is highly accurate in patients with Stage 1 disease. This research study, titled “Highly-accurate metabolomic detection of early-stage ovarian cancer,” was published in the Nov. 17 issue of Nature’s online journal “Scientific Reports.”
Help employers find you! Check out all the jobs and post your resume.
